387 related articles for article (PubMed ID: 28398951)
21. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
Lawless M; Gulati R; Tretiakova M
Histopathology; 2017 Sep; 71(3):406-414. PubMed ID: 28470753
[TBL] [Abstract][Full Text] [Related]
22. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens.
Paner GP; Brown JG; Lapetino S; Nese N; Gupta R; Shen SS; Hansel DE; Amin MB
Am J Surg Pathol; 2010 Jun; 34(6):792-9. PubMed ID: 20421781
[TBL] [Abstract][Full Text] [Related]
24. pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.
Sato S; Yanagisawa T; Miki J; Hayashida Y; Okada Y; Iwatani K; Matsukawa A; Kimura T; Egawa S; Shimoda M; Takahashi H
Arch Pathol Lab Med; 2024 May; 148(5):573-580. PubMed ID: 37671794
[TBL] [Abstract][Full Text] [Related]
25. Subcategorization of T1 Bladder Cancer on Biopsy and Transurethral Resection Specimens for Predicting Progression.
Budina A; Farahani SJ; Lal P; Nayak A
Arch Pathol Lab Med; 2022 Sep; 146(9):1131-1139. PubMed ID: 34871364
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion.
Brimo F; Wu C; Zeizafoun N; Tanguay S; Aprikian A; Mansure JJ; Kassouf W
Hum Pathol; 2013 Jan; 44(1):95-102. PubMed ID: 22939956
[TBL] [Abstract][Full Text] [Related]
27. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
[TBL] [Abstract][Full Text] [Related]
28. Staging of bladder cancer.
Magers MJ; Lopez-Beltran A; Montironi R; Williamson SR; Kaimakliotis HZ; Cheng L
Histopathology; 2019 Jan; 74(1):112-134. PubMed ID: 30565300
[TBL] [Abstract][Full Text] [Related]
29. Microstaging of pT1 transitional cell carcinoma of the bladder. Does it really differentiate two populations with different prognoses? (pT1 subcategory).
Sözen S; Akbal C; Sökmensüer C; Ekici S; Ozen H
Urol Int; 2002; 69(3):200-6. PubMed ID: 12372888
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.
Vallo S; Gilfrich C; Burger M; Volkmer B; Boehm K; Rink M; Chun FK; Roghmann F; Novotny V; Mani J; Brisuda A; Mayr R; Stredele R; Noldus J; Schnabel M; May M; Fritsche HM; Pycha A; Martini T; Wirth M; Roigas J; Bastian PJ; Nuhn P; Dahlem R; Haferkamp A; Fisch M; Aziz A
Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218
[TBL] [Abstract][Full Text] [Related]
31. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
32. Is restaging transurethral resection necessary in patients with non-muscle invasive bladder cancer and limited lamina propria invasion?
Audenet F; Retinger C; Chien C; Benfante NE; Bochner BH; Donat SM; Herr HW; Dalbagni G
Urol Oncol; 2017 Oct; 35(10):603.e1-603.e5. PubMed ID: 28689694
[TBL] [Abstract][Full Text] [Related]
33. Stage pT1 bladder carcinoma: diagnostic criteria, pitfalls and prognostic significance.
Lopez-Beltran A; Cheng L
Pathology; 2003 Dec; 35(6):484-91. PubMed ID: 14660098
[TBL] [Abstract][Full Text] [Related]
34. Microstaging of pT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression.
Smits G; Schaafsma E; Kiemeney L; Caris C; Debruyne F; Witjes JA
Urology; 1998 Dec; 52(6):1009-13; discussion 1013-4. PubMed ID: 9836546
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and substaging of pT1 bladder cancer].
Cheng L; Huang WB; Zheng SQ; Zheng J
Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458
[No Abstract] [Full Text] [Related]
36. Usefulness of pT1 substaging in papillary urothelial bladder carcinoma.
Patriarca C; Hurle R; Moschini M; Freschi M; Colombo P; Colecchia M; Ferrari L; Guazzoni G; Conti A; Conti G; Lucianò R; Magnani T; Colombo R
Diagn Pathol; 2016 Jan; 11():6. PubMed ID: 26791567
[TBL] [Abstract][Full Text] [Related]
37. The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder.
Younes M; Sussman J; True LD
Cancer; 1990 Aug; 66(3):543-8. PubMed ID: 2364365
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of urothelial carcinoma ambiguous for muscularis propria invasion on initial transurethral resection of bladder tumor.
Hassan O; Murati Amador B; Lombardo KA; Salles D; Cuello F; Marwaha AS; Daniels MJ; Kates M; Bivalacqua TJ; Matoso A
World J Urol; 2020 Feb; 38(2):389-395. PubMed ID: 31030230
[TBL] [Abstract][Full Text] [Related]
39. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal.
Cheng L; Weaver AL; Neumann RM; Scherer BG; Bostwick DG
Cancer; 1999 Sep; 86(6):1035-43. PubMed ID: 10491531
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.
Kamiya N; Suzuki H; Suyama T; Kobayashi M; Fukasawa S; Sekita N; Mikami K; Nihei N; Naya Y; Ichikawa T
Int J Clin Oncol; 2017 Apr; 22(2):353-358. PubMed ID: 27744487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
